| Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ... International immunopharmacology 88, 106869, 2020 | 65 | 2020 |
| COVID19 prevention & care; a cancer specific guideline A Motlagh, M Yamrali, S Azghandi, P Azadeh, M Vaezi, F Ashrafi, ... Archives of Iranian medicine 23 (4), 255-264, 2020 | 54 | 2020 |
| Prevalence of oral human papilloma virus in healthy individuals in East azerbaijan province of iran S Seifi, IA Kermani, R Dolatkhah, AA Kermani, E Sakhinia, M Asgarzadeh, ... Iranian journal of public health 42 (1), 79, 2013 | 39 | 2013 |
| Circulating free DNA concentration as a marker of disease recurrence and metastatic potential in lung cancer H Mirtavoos-Mahyari, S Ghafouri-Fard, A Khosravi, E Motevaseli, ... Clinical and translational medicine 8, 1-6, 2019 | 32 | 2019 |
| Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer IA Kermani, HT Kojidi, JV Gharamaleki, Z Sanaat, JE Ziaei, A Esfahani, ... Asian Pac J Cancer Prev 12 (6), 1381-4, 2011 | 29 | 2011 |
| Human papilloma virus in head and neck squamous cell cancer IA Kermani, SH Seifi, R Dolatkhah, E Sakhinia, S Dastgiri, A Ebrahimi, ... Iranian journal of cancer prevention 5 (1), 21, 2012 | 23 | 2012 |
| NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals M Marjani, P Tabarsi, A Moniri, SM Hashemian, SA Nadji, Z Abtahian, ... Tanaffos 19 (2), 91, 2020 | 18 | 2020 |
| Serum interleukin-27 level in different clinical stages of lung cancer AS Babadi, A Kiani, E Mortaz, K Taghavi, A Khosravi, M Marjani, S Seifi, ... Open Access Macedonian Journal of Medical Sciences 7 (1), 45, 2019 | 17 | 2019 |
| Clinicopathologic and survival characteristics of malignant pleural mesothelioma registered in hospital cancer registry K Najmi, A Khosravi, S Seifi, H Emami, S Chaibakhsh, G Radmand, ... Tanaffos 13 (2), 6, 2014 | 16 | 2014 |
| Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients SM Haghgoo, A Khosravi, E Mortaz, M Pourabdollah-Toutkaboni, S Seifi, ... Clinical Biochemistry 50 (6), 293-300, 2017 | 14 | 2017 |
| Comparing docetaxel plus cisplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: A single institute study K Khodadad, A Khosravi, Z Esfahani-Monfared, S Karimi, S Seifi Iranian Journal of Pharmaceutical Research: IJPR 13 (2), 575, 2014 | 14 | 2014 |
| Modifications in breast cancer guidelines in COVID-19 pandemic; an Iranian Consensus F Shahi, M Mirzania, M Aghili, M Dabiri, S Seifi, A Bary, N Ansarinejad, ... Archives of Breast Cancer, 14-21, 2020 | 12 | 2020 |
| Inflammatory potential of diet and odds of lung cancer: a case-control study A Sadeghi, K Parastouei, S Seifi, A Khosravi, B Salimi, H Zahedi, ... Nutrition and cancer 74 (8), 2859-2867, 2022 | 10 | 2022 |
| An overview on the upper and lower airway microbiome in cystic fibrosis patients M Meskini, SD Siadat, S Seifi, A Movafagh, M Sheikhpour Tanaffos 20 (2), 86, 2021 | 10 | 2021 |
| Favipiravir effects on the control of clinical symptoms of hospitalized COVID-19 cases: an experience with Iranian formulated dosage form P Tabarsi, H Vahidi, A Saffaei, SMR Hashemian, H Jammati, B Daraei, ... Iranian Journal of Pharmaceutical Research: IJPR 20 (4), 1, 2021 | 9 | 2021 |
| Clinical manifestations of patients with coronavirus disease 2019 (COVID-19) in a referral center in Iran P Baghaei, SA Nadji, M Marjani, A Moniri, SM Hashemian, H Sheikhzade, ... Tanaffos 19 (2), 122, 2020 | 9 | 2020 |
| No evidence for a role of Merkel cell polyomavirus in small cell lung cancer among Iranian subjects S Karimi, F Yousefi, S Seifi, A Khosravi, SA Nadji Pathology-Research and Practice 210 (12), 836-839, 2014 | 9 | 2014 |
| Vincristine-induced seizure potentiated by itraconazole following RCHOP chemotherapy for diffuse large B-cell lymphoma F Foroughinia, S Baniasadi, S Seifi, F Fahimi Current Drug Safety 7 (5), 372-374, 2012 | 8 | 2012 |
| National research institute of tuberculosis and lung disease (NRITLD) protocol for the treatment of patients with COVID-19 MS Mirenayat, A Abedini, A Kiani, A Eslaminejad, M Malekmohammad, ... Iranian Journal of Pharmaceutical Research: IJPR 21 (1), 2022 | 6 | 2022 |
| Bilateral lymphoblastic lymphoma of breast mimicking inflammatory breast cancer: a case report and review of literature S Seifi, Z Esfahani-Monfared, A Khosravi, N Kamalian, F Eshaghi, ... Tanaffos 14 (1), 63, 2015 | 6 | 2015 |
